Načítá se...
Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy
Development of pulmonary hypertension after initiation of diazoxide for the treatment of neonatal hyperinsulinemic hypoglycemia is a rare, but previously described association. Risk factors for development of diazoxide-associated pulmonary hypertension include lower gestational age and congenital he...
Uloženo v:
| Vydáno v: | Pulm Circ |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869162/ https://ncbi.nlm.nih.gov/pubmed/33614015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020987117 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|